GO:1905750 negative regulation of endosome to plasma membrane protein transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905750 describes any process that stops, prevents, or reduces the frequency, rate, or extent of protein transport from endosomes back to the plasma membrane.
• This negative regulation is essential for controlling receptor recycling, signaling duration, and cellular homeostasis.
• Key molecular players include ESCRT components, AP-1 clathrin adaptors, and phosphatidylinositol 3-phosphate regulators.
• Dysregulation of this process is linked to inflammatory signaling, cancer, and viral pathogenesis.
• CRISPR knockout, knock-in, and overexpression models enable precise dissection of this regulatory pathway.
• Understanding this term aids in identifying therapeutic targets for diseases involving aberrant endosomal trafficking.
Description
The endosomal system serves as a central hub for sorting proteins destined for degradation or recycling back to the plasma membrane. The term GO:1905750, negative regulation of endosome to plasma membrane protein transport, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of protein transport from endosomes to the plasma membrane. This regulatory mechanism is critical for maintaining cellular homeostasis by controlling the surface expression of receptors, transporters, and signaling molecules. Dysregulation of this process can lead to prolonged or aberrant signaling, contributing to diseases such as cancer and inflammatory disorders. Researchers study this term to understand how cells fine-tune membrane protein recycling and to identify therapeutic targets for diseases where endosomal trafficking is perturbed.
negative regulation of endosome to plasma membrane protein transport At A Glance
| GO ID | GO:1905750 |
|---|---|
| GO term | negative regulation of endosome to plasma membrane protein transport |
| Ontology | biological_process |
| Synonym | down regulation of endosome to plasma membrane protein transport, down-regulation of endosome to plasma membrane protein transport, downregulation of endosome to plasma membrane protein transport, inhibition of endosome to plasma membrane protein transport |
| Major function | Negative regulation of protein transport from endosomes to the plasma membrane |
| Related processes | Endosomal sorting, receptor recycling, signal termination |
| Key regulators | ESCRT complex, AP-1, phosphatidylinositol 3-phosphate |
| Disease relevance | Inflammation, cancer, viral infection |
What Is GO:1905750?
According to the Gene Ontology, GO:1905750 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of endosome to plasma membrane protein transport. In other words, it is the negative regulation of the directed movement of proteins from endosomes back to the plasma membrane. This biological process ensures that proteins are not excessively recycled, thereby controlling the composition of the plasma membrane and downstream signaling events.
Why Is negative regulation of endosome to plasma membrane protein transport Important in Cell Biology?
Negative regulation of endosome to plasma membrane protein transport is crucial for preventing excessive recycling of signaling receptors, which can lead to uncontrolled cell proliferation and inflammation. For example, the termination of STING signaling depends on clathrin-associated AP-1, which controls the endosomal trafficking of STING and prevents persistent immune activation. Similarly, ESCRT-dependent membrane repair negatively regulates pyroptosis by limiting the plasma membrane localization of GSDMD. Thus, this process is a key checkpoint in cellular signaling and immune responses.
• Controls the duration and intensity of receptor signaling by limiting recycling.
• Prevents aberrant immune activation by terminating STING signaling.
• Regulates cell death pathways such as pyroptosis and ferroptosis.
• Influences viral pathogenesis by modulating endosomal trafficking.
• Impacts cancer development through altered growth factor receptor recycling.
• Maintains neuronal homeostasis by regulating endosomal transport.
• Provides targets for anti-inflammatory therapies.
• Plays a role in autophagy and mitophagy regulation.
• Affects lipid metabolism and membrane repair.
• Is essential for proper development and tissue homeostasis.
What Happens During negative regulation of endosome to plasma membrane protein transport?
Recognition and Sorting of Cargo
In simple terms: The cell identifies proteins that should not go back to the surface.
Negative regulation begins with the recognition of cargo proteins that are destined for recycling. This often involves ubiquitination or other post-translational modifications that serve as sorting signals. The ESCRT complex plays a key role in recognizing ubiquitinated cargo and directing them to intraluminal vesicles of multivesicular bodies, thereby preventing their return to the plasma membrane. Additionally, phosphatidylinositol 3-phosphate levels are tightly regulated during early-to-late endosome conversion, influencing cargo sorting.
Retention in Endosomal Compartments
In simple terms: Proteins are held inside the endosome instead of being sent back.
Once cargo is sorted, it can be retained in endosomal compartments through interactions with specific adaptor proteins. For instance, the clathrin-associated AP-1 complex controls the termination of STING signaling by retaining STING in endosomes, preventing its recycling to the plasma membrane. This retention is essential for signal termination and prevents sustained immune activation.
Degradation or Alternative Trafficking
In simple terms: Some proteins are sent for destruction or to other destinations.
Negative regulation can also involve directing cargo to lysosomes for degradation. ESCRT-III-dependent membrane repair blocks ferroptosis by promoting the removal of damaged membrane proteins from the plasma membrane, thus negatively regulating their transport from endosomes. Similarly, ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation by limiting the plasma membrane localization of GSDMD.
Signal Termination and Feedback
In simple terms: The process shuts down signals that would otherwise continue.
By preventing the return of signaling receptors to the plasma membrane, negative regulation ensures timely signal termination. For example, TLR4 and CD14 trafficking is modulated to influence LPS-induced pro-inflammatory signaling, where negative regulation of endosome to plasma membrane transport helps resolve inflammation. This feedback mechanism is critical for preventing chronic inflammatory diseases.
Key Genes Involved in GO:1905750 negative regulation of endosome to plasma membrane protein transport
The following genes and proteins are key players in the negative regulation of endosome to plasma membrane protein transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESCRT components | Recognize and sort ubiquitinated cargo for degradation | Central to negative regulation; mutations linked to neurodegeneration |
| AP-1 | Clathrin adaptor controlling STING endosomal retention | Terminates STING signaling; target for autoimmune diseases |
| VPS4A | ESCRT-III ATPase involved in membrane remodeling | Hijacked by viruses; role in autophagy |
| GSDMD | Pore-forming protein regulated by ESCRT-dependent repair | Involved in pyroptosis; negative regulation prevents cell death |
| STING | Immune adaptor protein; its trafficking is negatively regulated | Dysregulation causes autoinflammatory diseases |
| TLR4 | Pattern recognition receptor; trafficking influences signaling | Negative regulation limits LPS-induced inflammation |
| CD14 | Co-receptor for LPS; endosomal trafficking regulated | Modulates TLR4 signaling |
| CARD14 | Signalosome component; endosomal relocation linked to mTORC1 | Associated with psoriasis; endosomal trafficking affects signaling |
| PI3P | Phosphatidylinositol 3-phosphate; regulates endosome conversion | Negative regulation of PI3P levels controls cargo sorting |
| mTORC1 | Kinase complex; influences endosomal trafficking | Links nutrient signaling to endosomal transport |
| LC3 | Autophagy marker; involved in phagophore closure | ESCRT-III and VPS4A promote LC3 lipidation |
| Ferroptosis regulators | Proteins involved in lipid peroxidation and membrane repair | ESCRT-III-dependent repair blocks ferroptosis |
| Pyroptosis regulators | Proteins controlling inflammatory cell death | ESCRT-dependent repair negatively regulates pyroptosis |
| Endosomal sorting complexes | Multiprotein complexes that sort cargo | Key to negative regulation of recycling |
| Rab GTPases | Regulate vesicle trafficking | Modulate endosome to plasma membrane transport |
| SNARE proteins | Mediate membrane fusion | Involved in recycling; negative regulation affects their availability |
| Ubiquitin ligases | Attach ubiquitin to cargo for sorting | Determine cargo fate in endosomes |
How Is negative regulation of endosome to plasma membrane protein transport Regulated?
The negative regulation of endosome to plasma membrane protein transport is itself subject to regulation by various signaling pathways. For instance, mTORC1 signaling influences endosomal relocation of CARD14, affecting keratinocyte proliferation. Phosphatidylinositol 3-phosphate levels are dynamically regulated during early-to-late endosome conversion, which impacts cargo sorting and subsequent transport. Additionally, ESCRT components are regulated by post-translational modifications and interactions with viral proteins, as seen with classical swine fever virus hijacking ESCRT-III and VPS4A.
negative regulation of endosome to plasma membrane protein transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STING | Autoinflammatory diseases (e.g., SAVI) | Knockout or point-mutation in immune cells |
| GSDMD | Pyroptosis-related inflammatory diseases | Knockout macrophages |
| ESCRT components | Neurodegeneration | Knockout neurons |
| CARD14 | Psoriasis | Knock-in keratinocytes |
| VPS4A | Viral infection | Knockout hepatocytes |
Inflammation and Autoimmunity
Dysregulation of negative regulation of endosome to plasma membrane protein transport can lead to persistent inflammatory signaling. For example, failure to terminate STING signaling due to impaired AP-1 function results in autoinflammatory diseases. Similarly, altered TLR4 and CD14 trafficking contributes to chronic inflammation in conditions such as sepsis.
Cancer
Aberrant endosomal recycling of growth factor receptors can promote cancer. Negative regulation of this transport is essential to prevent excessive receptor recycling. CARD14 signalosome formation and endosomal relocation are associated with mTORC1-induced keratinocyte proliferation, linking this process to proliferative skin diseases and potentially cancer.
Neurodegeneration
ESCRT dysfunction impairs the negative regulation of endosome to plasma membrane transport, leading to accumulation of toxic proteins. This is implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where endosomal trafficking defects are common.
Viral Infection
Viruses often hijack endosomal trafficking pathways. Classical swine fever virus exploits ESCRT-III and VPS4A to promote phagophore closure, enhancing mitophagy and viral replication. This highlights how pathogens manipulate negative regulation for their benefit.
From negative regulation of endosome to plasma membrane protein transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate endosome to plasma membrane transport? | CRISPR knockout cell line |
| How does a disease-associated mutation affect transport? | Point-mutation knock-in |
| Where does the protein localize during transport? | Tagged knock-in (e.g., GFP) |
| What happens when the gene is overexpressed? | Overexpression cell line |
| Which genes are essential for this process? | CRISPR library screening |
| What are the transcriptomic changes upon perturbation? | RNA-seq after knockout |
How to Study the negative regulation of endosome to plasma membrane protein transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Protein localization and trafficking | Visualize endosome to plasma membrane transport |
| Proximity labeling (BioID) | Protein-protein interactions | Identify regulators of endosomal sorting |
| CRISPR knockout screen | Gene essentiality for transport | Discover negative regulators |
| Subcellular fractionation | Protein distribution | Quantify endosomal vs. plasma membrane pools |
| RNA-seq | Transcriptional changes | Assess global effects of perturbation |
| Western blot | Protein levels and modifications | Validate knockout or overexpression |
| Live-cell imaging | Real-time trafficking | Track recycling kinetics |
| Flow cytometry | Surface protein expression | Measure recycling efficiency |
Imaging-Based Methods
Fluorescence microscopy and live-cell imaging are used to track the movement of proteins from endosomes to the plasma membrane. Tagged proteins (e.g., GFP) allow visualization of trafficking dynamics. For example, STING trafficking was monitored using confocal microscopy.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify proteins that interact with endosomal compartments and regulate transport. Proximity labeling techniques such as BioID can map the interactome of key regulators.
Genetic Screens
CRISPR knockout screens are powerful for identifying genes that negatively regulate endosome to plasma membrane transport. For instance, a genome-wide screen could reveal novel ESCRT components or adaptors.
Biochemical Assays
Subcellular fractionation followed by Western blotting can quantify the distribution of proteins between endosomes and plasma membrane. This method was used to study GSDMD localization.
How CRISPR Can Be Used to Study GO:1905750 negative regulation of endosome to plasma membrane protein transport
Knockout
CRISPR knockout of genes such as ESCRT components or AP-1 can abolish negative regulation, leading to increased endosome to plasma membrane transport. This approach helps identify essential regulators and their downstream effects.
Point Mutation
Introducing disease-associated point mutations (e.g., in STING) via CRISPR can reveal how specific residues affect endosomal retention and signaling. This is crucial for understanding autoinflammatory diseases.
Knock-in
Tagged knock-in of genes like GSDMD allows real-time tracking of their trafficking and localization. This provides insights into the spatiotemporal regulation of transport.
Overexpression
Overexpressing negative regulators can enhance the block of endosome to plasma membrane transport, mimicking a disease state or protective mechanism. This is useful for gain-of-function studies.
How EDITGENE Supports negative regulation of endosome to plasma membrane protein transport Research
Researchers studying negative regulation of endosome to plasma membrane protein transport-related genes often need to determine whether a candidate gene is causally involved in this process or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic perturbations and functional validation.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of endosome to plasma membrane protein transport research.
Frequently Asked Questions About negative regulation of endosome to plasma membrane protein transport
What is GO:1905750?
GO:1905750 is the Gene Ontology term for negative regulation of endosome to plasma membrane protein transport, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of protein transport from endosomes to the plasma membrane.
What genes are involved in negative regulation of endosome to plasma membrane protein transport?
Key genes include ESCRT components, AP-1, STING, GSDMD, VPS4A, and CARD14, among others.
How does negative regulation of endosome to plasma membrane transport affect inflammation?
It terminates signaling by preventing recycling of receptors like TLR4 and STING, thus limiting inflammatory responses.
What diseases are associated with defects in this process?
Diseases include autoinflammatory conditions, cancer, neurodegeneration, and viral infections.
What methods are used to study this process?
Common methods include fluorescence microscopy, CRISPR screens, proteomics, and subcellular fractionation.
Can CRISPR be used to study negative regulation of endosome to plasma membrane transport?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect this pathway.
What is the role of ESCRT in this process?
ESCRT complexes recognize and sort ubiquitinated cargo for degradation, preventing their recycling to the plasma membrane.
How does AP-1 regulate STING trafficking?
AP-1 controls the termination of STING signaling by retaining STING in endosomes, thus negatively regulating its transport to the plasma membrane.
What is the link between this process and cell death?
Negative regulation of endosome to plasma membrane transport can block pyroptosis and ferroptosis by limiting the surface localization of pore-forming proteins.
Why is this GO term important for drug discovery?
It represents a key checkpoint in receptor recycling and signaling, offering targets for anti-inflammatory and anticancer therapies.
Conclusion
The negative regulation of endosome to plasma membrane protein transport (GO:1905750) is a fundamental cellular process that controls the surface expression of proteins and the duration of signaling events. Its dysregulation is implicated in a wide range of diseases, from autoimmunity to cancer. Understanding the molecular players and mechanisms, such as ESCRT and AP-1, provides opportunities for therapeutic intervention. EDITGENE offers advanced CRISPR tools to facilitate research in this field, enabling precise genetic perturbations and functional studies.
References
- 1. Ciesielska A et al.. 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.. Cell Mol Life Sci 78(4):1233-1261 PMID: 33057840
- 2. Rühl S et al.. 2018. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation.. Science 362(6417):956-960 PMID: 30467171
- 3. Liu Y et al.. 2022. Clathrin-associated AP-1 controls termination of STING signalling.. Nature 610(7933):761-767 PMID: 36261523
- 4. Roxrud I et al.. 2010. ESCRT & Co.. Biol Cell 102(5):293-318 PMID: 20222872
- 5. Liu K et al.. 2016. Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion.. J Cell Biol 212(2):181-98 PMID: 26783301
- 6. O'Sullivan PA et al.. 2024. CARD14 signalosome formation is associated with its endosomal relocation and mTORC1-induced keratinocyte proliferation.. Biochem J 481(18):1143-1171 PMID: 39145956
- 7. Cheng Y et al.. 2025. Classical swine fever virus hijacks ESCRT-III and VPS4A to promote phagophore closure for accelerating mitophagy.. Autophagy 21(12):2709-2729 PMID: 40574328
- 8. Dai E et al.. 2020. ESCRT-III-dependent membrane repair blocks ferroptosis.. Biochem Biophys Res Commun 522(2):415-421 PMID: 31761326
